Transchem

Transchem EPS Growth

The EPS Growth of Transchem (500422.BO) as of Oct 21, 2026 is -17.81 %. In the previous year, EPS Growth was 24.33 % — a change of -173.22% (lower).

EPS Growth

-17.81 %

YoY

-173.22%

Last updated:

EPS Growth of Transchem is 2026 -17.81 % . EPS Growth of Transchem was 2025 24.33 % . It decreases by -173.22% lower compared to the previous year.

The Transchem EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2019
125.64 INR
Jan 1, 2020
34.27 INR
Jan 1, 2021
5,796.52 INR
Jan 1, 2022
-88.12 INR
Jan 1, 2023
-56.87 INR
Jan 1, 2024
239.78 INR
Jan 1, 2025
24.33 INR
Jan 1, 2026
-17.81 INR
The Transchem EPS Growth history
YEAREPS GrowthYoY
-17.81 %-173.22%
24.33 %-89.85%
239.78 %-521.64%
-56.87 %-35.47%
-88.12 %-101.52%
5,796.52 %+16,812.17%
34.27 %-72.72%
125.64 %-128.32%
-443.72 %-21.82%
-567.54 %+839.40%
-60.42 %-152.67%
114.70 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transchem Stock analysis

What does Transchem do? Transchem Ltd is a pharmaceutical company based in Thane, India, operating within the Health Care sector. The company has been publicly traded since its IPO on January 27, 1993, with a ticker symbol of 500422.BO and ISIN code INE019B01010. Its headquarters are located in Thane, Maharashtra. Transchem Ltd is engaged in the production and processing of pharmaceutical products, though specific product details are not provided. The company's website is https://www.transchem.net/. While the source description mentions the company's involvement in mushroom production, this appears to be an unverified or incorrect detail, as the company is classified under the Pharmaceuticals industry. The source also states that the company temporarily invests funds in short-term treasury operations while seeking new business opportunities, but this information should be treated with caution as it is not confirmed by official company sources. The company's primary focus remains on pharmaceutical manufacturing and processing within the Indian market. No additional details about its founding year, key personnel, acquisitions, or financial figures are provided in the available information. Transchem Ltd operates as a publicly listed entity on the Bombay Stock Exchange, though specific market capitalization or trading volume data is not included in the given facts. The company's activities are centered around pharmaceutical production, with no indication of other significant business lines beyond those related to the Health Care sector. Transchem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transchem stock

EPS Growth of Transchem is -17.81 % in 2026.

On Eulerpool you can find the complete historical development of EPS Growth Transchem since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Transchem historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Transchem

All Key Metrics — Transchem